Table 1.
Summary of the 55 studies included in the systematic review
Year of study | Country | Study type | First occurrence | Study quality a | |
---|---|---|---|---|---|
Villet WT et al. 16 | 1977 | South Africa | Case report | CLL first | 1 |
Weimar VM et al. 17 | 1979 | USA | Case series | CLL first and simultaneous CLL and cSCC | 1 |
Mora, RG 28 | 1985 | USA | Case report | CLL first | 1 |
Bridges N et al. 39 | 1986 | USA | Case report | CLL first | 1 |
Lishner M et al. 50 | 1987 | Israel | Case series | CLL first | 2 |
Perez‐Reyes N, Farhi DC. 61 | 1987 | USA | Retrospective cohort study | CLL first | 2 |
Frierson HF et al. 66 | 1988 | USA | Retrospective cohort study | CLL first | 2 |
Soares FA et al. 67 | 1992 | Brazil | Case report | Simultaneous CLL and cSCC | 1 |
Adami J et al. 68 | 1995 | Sweden, Denmark | Retrospective cohort study | CLL first and cSCC first | 2 |
Hartley BEJ et al. 69 | 1996 | UK | Case series | CLL first and cSCC first | 1 |
Levi F et al. 18 | 1996 | Switzerland | Retrospective cohort study | CLL first and cSCC first | 2 |
Davidovitz Y et al. 19 | 1997 | Israel | Case report | CLL first | 1 |
Dargent JL et al. 20 | 1998 | Belgium | Case report | CLL first | 1 |
Albregts T et al. 21 | 1998 | USA | Case report | CLL first | 1 |
Smoller BR et al. 22 | 1998 | USA | Case series | CLL first | 1 |
Gray Y et al. 23 | 2001 | USA | Case report | CLL first | 1 |
Smith KJ et al. 70 | 2001 | USA | Case series | Simultaneous CLL and cSCC | 1 |
Pigeaud‐Klessens ML et al. 24 | 2002 | Netherland | Case report | CLL first | 1 |
Larsen CR et al. 25 | 2002 | Denmark | Case series | CLL first | 1 |
Padgett JK et al. 26 | 2003 | USA | Case report | cSCC first | 1 |
Agnew KL et al. 27 | 2004 | UK | Retrospective cohort study | CLL first | 2 |
Rashid K et al. 29 | 2005 | USA | Case series | CLL first | 1 |
Sheahan P et al. 30 | 2005 | Ireland | Retrospective cohort study | SCC first | 2 |
Mehrany K et al. 31 | 2005 | USA | Retrospective case–control study | Simultaneous CLL and cSCC | 2 |
Mehrany K et al. 32 | 2005 | USA | Retrospective case–control study | Simultaneous CLL and cSCC | 2 |
Flezar MS et al. 33 | 2006 | Slovenia | Case series | CLL first | 1 |
Goh MSY 34 | 2006 | Australia | Case series | CLL first | 1 |
Wong J. et al. 35 | 2008 | Canada | Case report | CLL first | 1 |
Peng Y et al. 36 | 2009 | USA | Case report | CLL first | 1 |
Toro JR et al. 37 | 2009 | USA | Retrospective cohort study | cSCC first | 3 |
Hodges S. et al. 38 | 2010 | UK | Case report | Simultaneous CLL and cSCC | 1 |
Wilson ML et al. 40 | 2010 | USA | Case series | Simultaneous CLL and cSCC | 1 |
Tomaszewski JM et al. 41 | 2014 | Australia | Case series | CLL first | 1 |
Mansfield AS et al. 42 | 2014 | USA | Retrospective + prospective cohort study | CLL first | 2 |
Velez NF et al. 43 | 2014 | USA | Retrospective cohort study | CLL first | 3 |
Brewer JD et al. 44 | 2014 | USA | Retrospective cohort study | CLL first | 3 |
Tomaszewski JM et al. 45 | 2014 | Australia | Retrospective cohot study | CLL first | 3 |
Dos Santos HT et al. 46 | 2015 | Brazil | Case report | CLL first | 1 |
Vyas R et al. 47 | 2015 | USA | Case report | CLL first | 1 |
Gaide O et al. 48 | 2016 | Switzerland | Case report | CLL first | 1 |
Wollina U et al. 49 | 2016 | Germany | Case report | Simultaneous CLL and cSCC | 1 |
Hock BD et al. 51 | 2016 | New Zealand | Retrospective cohort study | CLL first | 2 |
Kader I et al. 52 | 2016 | Australia | Retrospective cohort study | CLL first | 2 |
Penne M et al. 53 | 2017 | USA | Retrospective cohort study | CLL first | 3 |
Hirshoren N et al. 54 | 2017 | Australia | Case series | cSCC first | 3 |
Hampras S.S et al. 55 | 2017 | USA | Retrospective cohort study | CLL first | 3 |
Callaghan DJ et al. 56 | 2018 | USA | Case series | cSCC first and simultaneous CLL and cSCC | 1 |
Wee E et al. 57 | 2018 | Australia | Retrospective cohort study | cSCC first | 2 |
Walz JS et al. 58 | 2018 | Germany | Retrospective cohort study | CLL first | 3 |
Rausch CR, Kontoyiannis DP 59 | 2019 | USA | Case report | CLL first | 1 |
Purcell RV et al. 60 | 2019 | New Zealand | Retrospective cohort study | CLL first | 3 |
Zheng G et al. 62 | 2019 | Sweden | Retrospective cohort study | CLL first and cSCC first | 2 |
Inda JJ et al. 63 | 2019 | USA | Retrospective cohort study | CLL first | 2 |
Thiesen I et al. 64 | 2019 | Germany | Retrospective cohort study | CLL first | 2 |
Wu PA et al. 65 | 2019 | USA | Retrospective cohort study | CLL first | 2 |
CLL, chronic lymphocytic leukemia; cSCC, cutaneous squamous cell carcinoma; UK, United Kingdom; USA, United States of America.
Based on Newcastle–Ottawa scale modified for case series and case reports: 1(worse) to 4 (better).